Carcinogenesis, Vol. 21, No. 8, 1537-1546,
August 2000
© 2000 Oxford University Press
Carcinogenesis |
A potential mechanism for fumonisin B1-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3ß activity
Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, Building 538, Room 205E, Frederick, MD 21702,
1 Clinical Research and Review Staff and
2 Division of Science and Applied Technology, Office of Special Nutritionals, Center for Food Safety and Applied Nutrition, Food and Drug Administration, Laurel, MD 20708,
3 Intramural Research Support Program, SAIC Frederick, NCI-Frederick Cancer Research and Development Center, Frederick, MD 21702,
4 Asthma and Allergy Center, Johns Hopkins University, Baltimore, MD 21224, USA,
5 Research Institute for Nutritional Diseases, South African Medical Research Council, PO Box 70 and
6 University of Stellenbosch, Medical Research Council Center for Molecular and Cellular Biology, PO Box 19063, Tygerberg 7505, South Africa
Fumonisin B1 (FB1) is a worldwide corn contaminant and has been epidemiologically linked to the high incidence of human esophageal cancer in South Africa and China. FB1 is hepatocarcinogenic in rats by an unknown mechanism. Inhibition of ceramide synthase and disruption of membrane phospholipids have been shown to be mechanisms of toxicity. Here we show overexpression of cyclin D1 protein in both preneoplastic and neoplastic liver specimens obtained from a long-term feeding study of FB1 in rats. In rats fed FB1 short-term, cyclin D1 protein levels in liver were increased up to five-fold in a dose-responsive manner. Northern blot analysis demonstrated no increase in mRNA levels of cyclin D1. 2D electrophoresis of cyclin D1 protein in FB1-treated samples showed a distinct pattern of migration (presence of less negatively charged form of the protein) that differed from controls. Recently, it has been shown that phosphorylation of cyclin D1 by glycogen synthase kinase 3ß (GSK-3ß) on a single threonine residue (Thr-286) positively regulates proteosomal degradation of cyclin D1. In FB1-treated samples we detected GSK-3ß phosphorylated on serine 9; activated protein kinase B (Akt) appears to be responsible for this activity-inhibiting phosphorylation. These findings suggest that overexpression of cyclin D1 results from stabilization due to a lack of phosphorylation mediated by GSK-3ß. We also observed an increase in cyclin dependent kinase 4 (Cdk4) complexes with cyclin D1 in FB1-treated samples; additionally, elevated Cdk4 activity was shown by increased phosphorylation of the retinoblastoma protein. In summary, the activation of Akt leads to increased survival, inhibition of GSK-3ß activity and post-translational stabilization of cyclin D1, all events responsible for disruption of the cell cycle G1/S restriction point in hepatocytes. This is the first report suggesting the mechanism by which FB1 acts as a carcinogen.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.-F. Lin, C.-L. Chen, C.-W. Chiang, M.-S. Jan, W.-C. Huang, and Y.-S. Lin GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis J. Cell Sci., August 15, 2007; 120(16): 2935 - 2943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fang, Q. Zhou, X.-l. Shi, and B.-h. Jiang Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells Carcinogenesis, March 1, 2007; 28(3): 713 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Voss, J. Liu, S. P. Anderson, C. Dunn, J. D. Miller, J. R. Owen, R. T. Riley, C. W. Bacon, and J. C. Corton Toxic Effects of Fumonisin in Mouse Liver Are Independent of the Peroxisome Proliferator-Activated Receptor {alpha} Toxicol. Sci., January 1, 2006; 89(1): 108 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Lemmer, C. J. Vessey, W. C. A. Gelderblom, E. G. Shephard, D. J. Van Schalkwyk, R. A. Van Wijk, W. F. O. Marasas, R. E. Kirsch, and P. d. l. M. Hall Fumonisin B1-induced hepatocellular and cholangiocellular tumors in male Fischer 344 rats: potentiating effects of 2-acetylaminofluorene on oval cell proliferation and neoplastic development in a discontinued feeding study Carcinogenesis, July 1, 2004; 25(7): 1257 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. F. O. Marasas, R. T. Riley, K. A. Hendricks, V. L. Stevens, T. W. Sadler, J. Gelineau-van Waes, S. A. Missmer, J. Cabrera, O. Torres, W. C. A. Gelderblom, et al. Fumonisins Disrupt Sphingolipid Metabolism, Folate Transport, and Neural Tube Development in Embryo Culture and In Vivo: A Potential Risk Factor for Human Neural Tube Defects among Populations Consuming Fumonisin-Contaminated Maize J. Nutr., April 1, 2004; 134(4): 711 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bouhet, E. Hourcade, N. Loiseau, A. Fikry, S. Martinez, M. Roselli, P. Galtier, E. Mengheri, and I. P. Oswald The Mycotoxin Fumonisin B1 Alters the Proliferation and the Barrier Function of Porcine Intestinal Epithelial Cells Toxicol. Sci., January 1, 2004; 77(1): 165 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Suliman, M. S. Carraway, K. E. Welty-Wolf, A. R. Whorton, and C. A. Piantadosi Lipopolysaccharide Stimulates Mitochondrial Biogenesis via Activation of Nuclear Respiratory Factor-1 J. Biol. Chem., October 17, 2003; 278(42): 41510 - 41518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhu, W. Jiang, H. E. Ganther, and H. J. Thompson Mechanisms of Cell Cycle Arrest by Methylseleninic Acid Cancer Res., January 1, 2002; 62(1): 156 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Klein and S. M. Fischer Black tea polyphenols inhibit IGF-I-induced signaling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells Carcinogenesis, January 1, 2002; 23(1): 217 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Holley, G. Parkes, C. Matthias, U. Bockmuhl, V. Jahnke, K. Leder, R. C. Strange, A. A. Fryer, and P. R. Hoban Cyclin D1 Polymorphism and Expression in Patients with Squamous Cell Carcinoma of the Head and Neck Am. J. Pathol., November 1, 2001; 159(5): 1917 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. P. Dragan, W. R. Bidlack, S. M. Cohen, T. L. Goldsworthy, G. C. Hard, P. C. Howard, R. T. Riley, and K. A. Voss Implications of Apoptosis for Toxicity, Carcinogenicity, and Risk Assessment: Fumonisin B1 as an Example Toxicol. Sci., May 1, 2001; 61(1): 6 - 17. [Abstract] [Full Text] [PDF]
|
|